about
The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms.PTEN: Multiple Functions in Human Malignant TumorsPTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer.Advances towards the design and development of personalized non-small-cell lung cancer drug therapy.Signaling intermediates (MAPK and PI3K) as therapeutic targets in NSCLC.PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting.Hepatic mitochondrial energetics during catch-up fat after caloric restriction.mTOR Cross-Talk in Cancer and Potential for Combination Therapy.Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer.Role of mTOR Signaling in Tumor Microenvironment: An OverviewSemaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-MybAdvances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer.Mitochondrial energetics in liver and skeletal muscle after energy restriction in young ratsHepatic mitochondrial energetics during catch-up fat with high-fat diets rich in lard or safflower oilTherapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor modelsFrom Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic CancerTranslational Landscape of mTOR Signaling in Integrating Cues Between Cancer and Tumor MicroenvironmentPTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game AroundPTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
P50
Q34244242-7F2711CE-67F8-4D24-8AD1-30312D038B22Q35087328-8B5E02E3-4435-401A-9F1C-220EDF781020Q37655023-5186F495-0865-42EF-83C9-1A33DC295E13Q38148583-BABEB317-8323-4CC2-95BA-C996831F0AE1Q38153825-3EF35A95-5B45-468D-994D-4C68B9CF0FD1Q38236558-9DA00C5E-50B0-433B-947D-F15191D5B15EQ42465217-6A3FE7AF-E4F5-456B-A9BE-5BCD183E128AQ48530866-6ADBA186-8D7E-42CF-985F-615E46AD7CF2Q54356658-D71F7813-C070-4C96-A5D6-17A8937011EAQ58766017-0B1F4D0B-E0C0-47F4-B6C5-C25936B34A98Q59336612-2ACB9D86-3E4B-45FB-AB58-F46D30E26CEBQ64950548-7053FBC6-1328-4AEB-BFB9-B4A777C84A5EQ82514835-0C731D90-F955-4623-8805-01C26F84642BQ84483277-6032E19B-0C57-415A-BBFF-EAFD9E2EF762Q89478898-0B514206-8FCF-43D3-8603-2377F57C7407Q89510331-1A120C5B-D751-4C7C-8F4F-203CABFFEC84Q89587297-155E29BF-7A11-4CA1-A7B1-34CBCC338C11Q92569890-25DFDA22-8FDB-4F4A-8FD8-DB92D8EECDEFQ92702101-E55B2FC5-BAED-470C-BE18-E70CC666C66F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Italia Falcone
@ast
Italia Falcone
@en
Italia Falcone
@es
Italia Falcone
@nl
type
label
Italia Falcone
@ast
Italia Falcone
@en
Italia Falcone
@es
Italia Falcone
@nl
prefLabel
Italia Falcone
@ast
Italia Falcone
@en
Italia Falcone
@es
Italia Falcone
@nl
P106
P1153
36247082200
57200450909
P31
P496
0000-0003-2796-0792